pharmaphorum

JANUARY 11, 2021

US wholesale giant AmerisourceBergen is to buy the majority of Walgreens Boots Alliance’s wholesaling business for around $6.5 AmerisourceBergen will pay $6.275 billion in cash and around 2 million shares of its common stock for Alliance Healthcare in a deal to support its global distribution business.

65

65

Fierce Healthcare

APRIL 25, 2023

AmerisourceBergen, TPG to acquire specialty practice network OneOncology in $2.1B deal hlandi Tue, 04/25/2023 - 15:08

52

52

Drug Store News

AUGUST 31, 2023

Under the new name Cencora, the company unifies its 46,000 employee across several global business segments under one identity.

110

110

Outsourcing Pharma

SEPTEMBER 22, 2022

AmerisourceBergen has followed through on plans to grow its biopharma services business by striking a â1.28bn ($1.28bn) deal to acquire PharmaLex.

52

52

Drug Topics

NOVEMBER 18, 2022

Jay Dombi and Lamont Robinson share how the AmerisourceBergen Marketplace can help pharmacies and why having diverse suppliers is important.

187

187

Drug Store News

JANUARY 24, 2023

The new name represents a unified presence that will continue to fuel the company’s ongoing growth strategy and advance its impact across health care, the company said.

105

105

Drug Topics

NOVEMBER 1, 2022

The company is leaning even more into specialty drugs, with a new distribution center in California, and innovating to meet the changing needs of customers.

76

76

Drug Topics

AUGUST 18, 2023

A Q&A with Matt Sample, senior vice president of manufacturer and replenishment operations at AmerisourceBergen.

98

98

PharmExec

SEPTEMBER 14, 2023

Lung-I Cheng, vice president of cell and gene therapy (CGT), Cencora (formerly AmerisourceBergen), discusses CGT commercialization strategies, common knowledge gaps, and what he wishes companies knew about commercialization strategies.

105

105

Pharmacy Times

JANUARY 17, 2023

The scholarship is accepting applications until February 28, 2023, and 4 pharmacy school students will be announced in April.

123

123

Pharmaceutical Commerce

SEPTEMBER 5, 2023

Shift comes with $5 million dedication to launch Cencora’s healthier futures grant program.

52

52

PharmExec

SEPTEMBER 1, 2023

Shift comes with $5 million dedication to launch Cencora’s healthier futures grant program.

52

52

Drug Store News

DECEMBER 8, 2022

Walgreens Boots Alliance’s ownership of AmerisourceBergen’s common stock decreased from approximately 20% to 17%.

98

98

Drug Store News

MAY 8, 2023

The two organizations have kicked off their collaboration with the co-creation of a telehealth solution focused on Test to Treat opportunities.

52

52

Pharmaceutical Commerce

APRIL 24, 2023

The platform agnostic CGT hub hopes to streamline the path-to-care process, by providing physicians and patient services teams with visibility across the therapy development and delivery process.

52

52

PharmExec

OCTOBER 3, 2023

Chandler discusses how life sciences companies are navigating the current climate.

111

111

Drug Store News

MAY 12, 2023

Proceeds to Walgreens Boots Alliance will be used primarily for debt paydown and general corporate purposes.

95

95

Pharmaceutical Technology

OCTOBER 23, 2023

H2O Therapeutics’s Parky app is a symptom tracker app designed to quantify the kinematics of movement disorder symptoms in PD patients.

52

52

Pharmacy Times

AUGUST 24, 2022

George Rafferty and Jason Dinger of AmerisourceBergen discuss the investment interests of the venture capital fund AB Health Ventures within the retail pharmacy space.

65

65

Pharmaceutical Commerce

JANUARY 5, 2023

Provider’s regulatory affairs, pharmacovigilance services expected to help increase ABC’s portfolio.

52

52

Pharmaceutical Commerce

MARCH 28, 2023

AmerisourceBergen exec explains how his experience in health policy analysis and data analytics helps him tackle patient access obstacles.

52

52

Pharmaceutical Commerce

JANUARY 24, 2023

Reflects company’s identity and pharma supply chain impact

52

52

Drug Store News

APRIL 28, 2023

The investment further strengthens AmerisourceBergen’s solutions in specialty.

52

52

Pharmaceutical Commerce

MARCH 28, 2023

AmerisourceBergen exec highlights his 'state of the industry' address that he made at day one of the conference.

52

52

Pharmaceutical Commerce

SEPTEMBER 19, 2022

With deal, drug wholesaler grows its biopharma services platform.

52

52

Outsourcing Pharma

JULY 15, 2022

Clinical Trial Navigator, from AmerisourceBergen, is designed to help sponsors pair with oncology practices to boost patient recruitment opportunities.

52

52

Pharmaceutical Commerce

MARCH 28, 2023

AmerisourceBergen exec dives into the shift in Medicare Part D patient requirements.

52

52

STAT

JANUARY 3, 2023

Good morning, everyone, and welcome to a new year. We hope the holiday respite was refreshing and inspiring, because that oh-so-familiar routine of online meetings, calls, and deadlines — otherwise known as work — has predictably returned. But what can you do? The world, such as it is, continues to spin.

62

62

Pharmaceutical Technology

OCTOBER 31, 2022

In preparation for ONS-5010's anticipated approval and commercial launch, the company has recently entered a strategic commercialisation agreement with AmerisourceBergen. Under the deal, AmerisourceBergen will be responsible for providing third-party logistics (3PL) services, distribution, along with pharmacovigilance services in the US.

FDA 59

FDA Compounding Pharmacies Labelling Compounding 59

pharmaphorum

JULY 6, 2022

A court in West Virginia has ruled that US drug distributors McKesson, AmerisourceBergen and Cardinal Health are not responsible for fuelling the opioid crisis that has claimed thousands of lives in the state. District court judge David Faber rejected a call by prosecutors to force the distributors to pay $2.5

Hospitals 59

Hospitals 59

pharmaphorum

MAY 12, 2022

In February, Johnson & Johnson and the ‘big three’ US pharma wholesalers – McKesson, Cardinal Health, and AmerisourceBergen – said they were close to finalising a $26 billion settlement to extricate themselves from opioid litigation and fund projects to prevent and treat opioid addiction.

92

92

pharmaphorum

NOVEMBER 2, 2022

The pharmacy chains are following in the footsteps of the big three US wholesaler distributors – McKesson, Cardinal Health and AmerisourceBergen – who agreed a $21 billion settlement earlier this year. spike in deaths in the 12 months to April 2021 to nearly 100,000. billion for Teva Pharmaceutical , $2.4 billion for AbbVie, $1.7

Immunization 95

Immunization 95

pharmaphorum

FEBRUARY 28, 2022

Under the terms, J&J would be in line for a $5 billion payment over nine years, while wholesalers McKesson, Cardinal Health and AmerisourceBergen would share responsibility for the remainder over an 18-year timeframe. None are admitting any wrongdoing.

59

59

pharmaphorum

JANUARY 28, 2021

In fact, at AmerisourceBergen, we’re seeing health system customers actively engage us about biosimilars and how to integrate these products into their formularies and care plans. Sean McGowan is responsible for leading strategy and business development initiatives for the Biosimilar product category at AmeriSourceBergen.

Insurance Coverage 101

Insurance Coverage FDA Insurance 101

pharmaphorum

JANUARY 19, 2022

The announcement comes at the same time as the state has finalised its nearly $300 million (£220 million) settlement with Johnson & Johnson that was announced in July, part of a multi-state settlement deal that also included distributors AmerisourceBergen, Cardinal Health, and McKesson.

52

52

pharmaphorum

NOVEMBER 16, 2022

The pharmacy chains are following in the footsteps of the big three US wholesaler distributors – McKesson, Cardinal Health, and AmerisourceBergen – who agreed a $21 billion settlement earlier this year. billion for Teva Pharmaceutical , $2.4 billion for AbbVie, $1.7 billion for Mallinckrodt , and $450 million for Endo Pharma.

Immunization 52

Immunization 52

pharmaphorum

DECEMBER 31, 2021

Other defendants who have opted to pay up include drugmakers AbbVie/Allergan and Endo health, which agreed $200 million and $50 million settlements, respectively, as well as medicine McKesson, Cardinal Health and AmerisourceBergen which have agreed a $1 billion package.

Packaging 52

Packaging Immunization 52